MedPath

The Use of a Fully Automated Pulsating Support System (CuroCell® A4 CX20) in Pressure Ulcer Prevention and Treatment

Not Applicable
Completed
Conditions
Pressure Ulcer, Buttock
Pressure Ulcer
Pressure Injury
Pressure Sore
Interventions
Device: 18 residents at least one PU category III-IV in the sacral area
Device: 22 residentsat risk for PU development
Registration Number
NCT04890678
Lead Sponsor
University Ghent
Brief Summary

Pressure Ulcers are a serious and common problem for residents admitted to long-term care facilities and community care patients. They represent a major burden to patients, carers and the Healthcare system, affecting approximately 1 in 20 community patients. International guidelines recommend the use of pressure redistribution support surfaces, systematic patient repositioning and preventive skin care to prevent pressure ulcers.

It has been acknowledged that a significant proportion of pressure ulcers are avoidable. The prevalence of pressure ulcers is 1 of the 4 common harms recorded in the UK NHS Safety Thermometer, a local improvement tool for measuring, monitoring and analyzing patient harms across a range of settings, including nursing homes, community nursing and hospitals on a monthly basis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • At risk of pressure ulcer development based on a Braden score ≤ 17 or pressure ulcer category III or IV
  • Bedbound or chair bound
  • Aged ≥ 65
Exclusion Criteria
  • Short-stay residents (expected length of stay ≤14 days)
  • End of life care
  • Medical contraindication for patient repositioning/turning

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
18 residents at least one PU category III-IV in the sacral area18 residents at least one PU category III-IV in the sacral area18 residents at least one PU category III-IV in the sacral area aged 65 years or over
22 residentsat risk for PU development22 residentsat risk for PU development22 residents at risk for PU development, defined by a Braden score \< 12 and/or a Braden subscale 'Mobility' score ≤ 2 and/or the presence of non-blanchable erythema in the sacral area. aged 65 years or over
Primary Outcome Measures
NameTimeMethod
Pressure ulcer incidence30 days

Development of at least 1 Pressure ulcer category II+ during study period using European Pressure Ulcer Advisory Panel (EPUAP) classification system

Pressure ulcer healing30 days

Healing of pressure ulcers category III and IV during the 30-day study period - using the Pressure Ulcer Scale for Healing Tool (PUSH)

Secondary Outcome Measures
NameTimeMethod
Comfort30 days

perceived comfort and experiences of users of the mattress - using self-developed questionnaire

Trial Locations

Locations (1)

WZC Hof ter Waarbeek

🇧🇪

Asse, Vlaams-Brabant, Belgium

© Copyright 2025. All Rights Reserved by MedPath